Literature DB >> 21187186

Venous thromboembolism with chronic liver disease.

Tarek Saleh1, Fadi Matta, Fadi Alali, Paul D Stein.   

Abstract

BACKGROUND: patients with chronic liver disease have both antithrombotic and prothrombotic coagulation abnormalities. Published data conflict on whether patients with chronic liver disease have a high or low prevalence of venous thromboembolism.
METHODS: the number of patients discharged from hospitals throughout the US with a diagnostic code for chronic alcoholic and chronic nonalcoholic liver disease from 1979 through 2006 was obtained from the National Hospital Discharge Survey. We compared prevalences of venous thromboembolism among patients with chronic alcoholic liver disease and chronic nonalcoholic liver disease.
RESULTS: among 4,927,000 hospitalized patients with chronic alcoholic liver disease from 1979-2006, the prevalence of venous thromboembolism was 0.6%, compared with 0.9% among 4,565,000 hospitalized patients with chronic nonalcoholic liver disease.
CONCLUSION: the prevalence of venous thromboembolism in hospitalized patients with chronic liver disease, both alcoholic and nonalcoholic, was low. The prevalence of venous thromboembolism was higher in those with chronic non-alcoholic liver disease, but the difference was small and of no clinical consequence. Based on the literature, both showed a lower prevalence of venous thromboembolism than in hospitalized patients with most other medical diseases. It may be that both chronic alcoholic liver disease and chronic nonalcoholic liver disease have protective antithrombotic mechanisms, although the mechanisms differ. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21187186     DOI: 10.1016/j.amjmed.2010.08.014

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.

Authors:  Xingshun Qi; Weirong Ren; Xiaozhong Guo; Daiming Fan
Journal:  Intern Emerg Med       Date:  2014-12-04       Impact factor: 3.397

Review 2.  Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.

Authors:  Ashish Aggarwal; Kanika Puri; Suthat Liangpunsakul
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

3.  Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.

Authors:  Michael Tischendorf; Wolfgang Miesbach; Umer Chattah; Zenab Chattah; Sebastian Maier; Christoph Welsch; Stefan Zeuzem; Christian M Lange
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

4.  Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment.

Authors:  Vincent Ten Cate; Brigitte Ab Essers; Martin H Prins
Journal:  BMJ Open       Date:  2017-05-10       Impact factor: 2.692

5.  Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.

Authors:  Jassin Rashidi-Alavijeh; Ayse S Ceylan; Heiner Wedemeyer; Martin Kleefisch; Katharina Willuweit; Christian M Lange
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

6.  Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.

Authors:  Xintong Zhang; Xingshun Qi; Valerio De Stefano; Feifei Hou; Zheng Ning; Jiancheng Zhao; Ying Peng; Jing Li; Han Deng; Hongyu Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-03-24

Review 7.  Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

Authors:  Alberto Zanetto; Elena Campello; Luca Spiezia; Patrizia Burra; Paolo Simioni; Francesco Paolo Russo
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.